| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.97e-10 | 37 | 91 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.63e-10 | 38 | 91 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 7.95e-10 | 11 | 91 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.41e-09 | 14 | 91 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.38e-08 | 21 | 91 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | nuclease activity | DXO ERVK-6 ERVK-7 ERVK-10 DNASE2B ERI3 ERVK-8 ERVK-11 REXO1L1P DNASE2 | 1.00e-07 | 231 | 91 | 10 | GO:0004518 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | DXO ERVK-6 CES1 PLA2G3 ERVK-7 ERVK-10 DNASE2B PTPRE SMPDL3A ERI3 PTPRQ ERVK-8 ERVK-11 TNS1 REXO1L1P GNS DNASE2 | 1.20e-07 | 807 | 91 | 17 | GO:0016788 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 6.83e-07 | 37 | 91 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 7.84e-07 | 38 | 91 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.08e-06 | 46 | 91 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.93e-06 | 136 | 91 | 7 | GO:0004519 | |
| GeneOntologyMolecularFunction | deoxyribonuclease II activity | 2.05e-05 | 2 | 91 | 2 | GO:0004531 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.04e-05 | 79 | 91 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 3.71e-05 | 136 | 91 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.96e-04 | 262 | 91 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 6.57e-04 | 152 | 91 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | immune receptor activity | 9.51e-04 | 165 | 91 | 5 | GO:0140375 | |
| GeneOntologyMolecularFunction | DNA endonuclease activity, producing 3'-phosphomonoesters | 1.10e-03 | 11 | 91 | 2 | GO:0016889 | |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 1.32e-03 | 12 | 91 | 2 | GO:0032396 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.82e-03 | 53 | 91 | 3 | GO:0030331 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 2.36e-03 | 16 | 91 | 2 | GO:0023029 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 ZNF212 UBR4 GATA6 ZDBF2 ERVK-7 ERVK-10 SMPDL3A ERVK-8 ERVK-19 ERVK-11 | 2.39e-03 | 891 | 91 | 11 | GO:0008270 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DXO ERVK-6 ERVK-7 ERVK-10 DNASE2B ERI3 ERVK-8 ERVK-11 DNASE2 | 2.69e-03 | 645 | 91 | 9 | GO:0140640 |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 ZNF212 UBR4 GATA6 ZDBF2 ERVK-7 ERVK-10 HEPH SMPDL3A AOC3 ERVK-8 ERVK-19 ERVK-11 | 2.79e-03 | 1189 | 91 | 13 | GO:0046914 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 2.96e-03 | 417 | 91 | 7 | GO:0140098 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 3.00e-03 | 18 | 91 | 2 | GO:0032393 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 3.34e-03 | 19 | 91 | 2 | GO:0032394 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 3.50e-03 | 430 | 91 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 SPEG ERVK-7 ERVK-10 TEX14 ITPKC LATS1 LATS2 CSF1R ERVK-8 ERVK-11 | 3.54e-03 | 938 | 91 | 11 | GO:0016772 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 3.70e-03 | 20 | 91 | 2 | GO:0016894 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 4.08e-03 | 21 | 91 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | growth factor binding | 5.66e-03 | 156 | 91 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 6.22e-03 | 26 | 91 | 2 | GO:0070412 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.87e-09 | 13 | 91 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.21e-06 | 48 | 91 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.31e-05 | 83 | 91 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 5.10e-05 | 218 | 91 | 7 | GO:0071897 | |
| GeneOntologyBiologicalProcess | inner cell mass cell fate commitment | 5.76e-05 | 3 | 91 | 2 | GO:0001827 | |
| GeneOntologyBiologicalProcess | inner cell mass cellular morphogenesis | 5.76e-05 | 3 | 91 | 2 | GO:0001828 | |
| Domain | DNase_II | 2.14e-05 | 2 | 87 | 2 | IPR004947 | |
| Domain | DNase_II | 2.14e-05 | 2 | 87 | 2 | PF03265 | |
| Domain | NPIP | 3.42e-05 | 14 | 87 | 3 | IPR009443 | |
| Domain | Ig-like_fold | IL10RA SEMA3F ROBO4 ADAMTSL1 SPEG SIGLEC5 FNDC1 CSF1R CRLF3 KIR3DL3 KIR3DL1 LILRA5 | 1.02e-04 | 706 | 87 | 12 | IPR013783 |
| Domain | IGc2 | 1.14e-04 | 235 | 87 | 7 | SM00408 | |
| Domain | Ig_sub2 | 1.14e-04 | 235 | 87 | 7 | IPR003598 | |
| Domain | IG | SEMA3F ROBO4 ADAMTSL1 SPEG SIGLEC5 CSF1R KIR3DL3 KIR3DL1 LILRA5 | 1.50e-04 | 421 | 87 | 9 | SM00409 |
| Domain | Ig_sub | SEMA3F ROBO4 ADAMTSL1 SPEG SIGLEC5 CSF1R KIR3DL3 KIR3DL1 LILRA5 | 1.50e-04 | 421 | 87 | 9 | IPR003599 |
| Domain | - | IL10RA SEMA3F ROBO4 ADAMTSL1 SPEG SIGLEC5 FNDC1 CSF1R CRLF3 KIR3DL1 LILRA5 | 2.51e-04 | 663 | 87 | 11 | 2.60.40.10 |
| Domain | Carboxylesterase_B_CS | 1.62e-03 | 13 | 87 | 2 | IPR019819 | |
| Domain | EXOIII | 1.88e-03 | 14 | 87 | 2 | SM00479 | |
| Domain | Exonuclease_RNaseT/DNA_pol3 | 1.88e-03 | 14 | 87 | 2 | IPR013520 | |
| Domain | RNase_T | 1.88e-03 | 14 | 87 | 2 | PF00929 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.88e-03 | 14 | 87 | 2 | PS00941 | |
| Domain | COesterase | 1.88e-03 | 14 | 87 | 2 | PF00135 | |
| Domain | CarbesteraseB | 1.88e-03 | 14 | 87 | 2 | IPR002018 | |
| Domain | ig | 1.95e-03 | 190 | 87 | 5 | PF00047 | |
| Domain | Immunoglobulin | 1.95e-03 | 190 | 87 | 5 | IPR013151 | |
| Domain | IG_LIKE | 2.05e-03 | 491 | 87 | 8 | PS50835 | |
| Domain | Ig-like_dom | 2.38e-03 | 503 | 87 | 8 | IPR007110 | |
| Domain | FN3_dom | 2.94e-03 | 209 | 87 | 5 | IPR003961 | |
| Domain | RNaseH-like_dom | 4.10e-03 | 69 | 87 | 3 | IPR012337 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-11 | 2.94e-10 | 94 | 99 | 8 | 21542922 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 3.08e-10 | 5 | 99 | 4 | 12629516 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 10516026 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 8.93e-08 | 4 | 99 | 3 | 10469592 | |
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 7983737 | ||
| Pubmed | 1.83e-07 | 18 | 99 | 4 | 18664271 | ||
| Pubmed | 4.83e-06 | 12 | 99 | 3 | 14557543 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 23824537 | ||
| Pubmed | Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer. | 8.02e-06 | 2 | 99 | 2 | 32423384 | |
| Pubmed | Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. | 8.02e-06 | 2 | 99 | 2 | 34060480 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 25482410 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 30671453 | ||
| Pubmed | Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. | 8.02e-06 | 2 | 99 | 2 | 17049657 | |
| Pubmed | Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance. | 8.02e-06 | 2 | 99 | 2 | 31268774 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 32826458 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 9060628 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 29730476 | ||
| Pubmed | The Hippo pathway regulates human megakaryocytic differentiation. | 8.02e-06 | 2 | 99 | 2 | 27786336 | |
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 8.02e-06 | 2 | 99 | 2 | 9460924 | |
| Pubmed | N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability. | 8.02e-06 | 2 | 99 | 2 | 23230145 | |
| Pubmed | Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. | 8.02e-06 | 2 | 99 | 2 | 12944971 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 12594037 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 28611271 | ||
| Pubmed | Cell type-dependent function of LATS1/2 in cancer cell growth. | 8.02e-06 | 2 | 99 | 2 | 30531839 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 15746036 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 19799973 | ||
| Pubmed | LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function. | 8.02e-06 | 2 | 99 | 2 | 31848340 | |
| Pubmed | Expression of LATS family proteins in ovarian tumors and its significance. | 8.02e-06 | 2 | 99 | 2 | 25841306 | |
| Pubmed | LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control. | 8.02e-06 | 2 | 99 | 2 | 32015438 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 25044019 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24026096 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 8.02e-06 | 2 | 99 | 2 | 11672541 | |
| Pubmed | A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway. | 2.40e-05 | 3 | 99 | 2 | 30308519 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 24012335 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 9971820 | ||
| Pubmed | Divergent origins and concerted expansion of two segmental duplications on chromosome 16. | 2.40e-05 | 3 | 99 | 2 | 11948212 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 18413746 | ||
| Pubmed | Tumor suppressor LATS1 is a negative regulator of oncogene YAP. | 2.40e-05 | 3 | 99 | 2 | 18158288 | |
| Pubmed | LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells. | 2.40e-05 | 3 | 99 | 2 | 35859006 | |
| Pubmed | Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. | 4.79e-05 | 4 | 99 | 2 | 28754671 | |
| Pubmed | HSP90β chaperoning SMURF1-mediated LATS proteasomal degradation in the regulation of bone formation. | 4.79e-05 | 4 | 99 | 2 | 36379376 | |
| Pubmed | Inactivation of the Hippo tumor suppressor pathway promotes melanoma. | 4.79e-05 | 4 | 99 | 2 | 35768444 | |
| Pubmed | Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. | 4.79e-05 | 4 | 99 | 2 | 21041411 | |
| Pubmed | Hippo signalling maintains ER expression and ER+ breast cancer growth. | 4.79e-05 | 4 | 99 | 2 | 33658690 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 20841485 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 32451369 | ||
| Pubmed | KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases. | 4.79e-05 | 4 | 99 | 2 | 21233212 | |
| Pubmed | The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis. | 4.79e-05 | 4 | 99 | 2 | 21822051 | |
| Pubmed | Phosphorylation of CHO1 by Lats1/2 regulates the centrosomal activation of LIMK1 during cytokinesis. | 4.79e-05 | 4 | 99 | 2 | 25786116 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 34831091 | ||
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 25658096 | ||
| Pubmed | Hippo signaling instructs ectopic but not normal organ growth. | 4.79e-05 | 4 | 99 | 2 | 36395225 | |
| Pubmed | Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. | 4.79e-05 | 4 | 99 | 2 | 15343267 | |
| Pubmed | 5.18e-05 | 71 | 99 | 4 | 12754519 | ||
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 31474569 | ||
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 24106267 | ||
| Pubmed | The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. | 7.98e-05 | 5 | 99 | 2 | 28068668 | |
| Pubmed | Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). | 7.98e-05 | 5 | 99 | 2 | 18640976 | |
| Pubmed | Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway. | 7.98e-05 | 5 | 99 | 2 | 26045165 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 7.98e-05 | 5 | 99 | 2 | 11401426 | |
| Pubmed | The Hippo pathway links adipocyte plasticity to adipose tissue fibrosis. | 7.98e-05 | 5 | 99 | 2 | 36229481 | |
| Pubmed | Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway. | 7.98e-05 | 5 | 99 | 2 | 32994166 | |
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 20624913 | ||
| Pubmed | Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis. | 7.98e-05 | 5 | 99 | 2 | 35191398 | |
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 26109051 | ||
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 32796823 | ||
| Pubmed | YAP/TAZ-CDC42 signaling regulates vascular tip cell migration. | 7.98e-05 | 5 | 99 | 2 | 28973878 | |
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 29438698 | ||
| Pubmed | The Hippo Pathway Blocks Mammalian Retinal Müller Glial Cell Reprogramming. | 7.98e-05 | 5 | 99 | 2 | 31067451 | |
| Pubmed | YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. | 7.98e-05 | 5 | 99 | 2 | 28805663 | |
| Pubmed | DNHD1 B3GNT4 ROBO4 MRI1 ADAMTSL1 GLB1L SEZ6L2 HEPH TMEM130 SGCE MFSD13A | 1.16e-04 | 985 | 99 | 11 | 12975309 | |
| Pubmed | Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. | 1.19e-04 | 6 | 99 | 2 | 20303269 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 31558567 | ||
| Pubmed | The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. | 1.19e-04 | 6 | 99 | 2 | 15688006 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 31941533 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 24101513 | ||
| Pubmed | A novel role for CD55 in granulocyte homeostasis and anti-bacterial host defense. | 1.19e-04 | 6 | 99 | 2 | 21984892 | |
| Pubmed | Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell. | 1.19e-04 | 6 | 99 | 2 | 31019301 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 31513574 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 15063128 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 29689192 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 30266805 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 23644383 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 38811804 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 19289085 | ||
| Pubmed | Development of a screening set for new (CAG/CTG)n dynamic mutations. | 1.19e-04 | 6 | 99 | 2 | 8786123 | |
| Pubmed | Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas. | 1.19e-04 | 6 | 99 | 2 | 36443313 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 32341094 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.30e-04 | 170 | 99 | 5 | 23314748 | |
| Pubmed | 1.67e-04 | 7 | 99 | 2 | 24255096 | ||
| Pubmed | YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. | 1.67e-04 | 7 | 99 | 2 | 29669762 | |
| Pubmed | YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice. | 1.67e-04 | 7 | 99 | 2 | 32900774 | |
| Pubmed | YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression. | 1.67e-04 | 7 | 99 | 2 | 31801083 | |
| Pubmed | Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. | 1.67e-04 | 7 | 99 | 2 | 31754005 | |
| Pubmed | 1.67e-04 | 7 | 99 | 2 | 12618911 | ||
| Pubmed | 1.67e-04 | 7 | 99 | 2 | 32960816 | ||
| Pubmed | YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis. | 1.67e-04 | 7 | 99 | 2 | 30582452 | |
| Pubmed | 1.67e-04 | 7 | 99 | 2 | 9694798 | ||
| Pubmed | 1.67e-04 | 7 | 99 | 2 | 33162027 | ||
| Pubmed | Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. | 1.67e-04 | 7 | 99 | 2 | 15748957 | |
| Cytoband | 16p12.2 | 6.95e-05 | 37 | 98 | 3 | 16p12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 1.75e-04 | 129 | 98 | 4 | chr2q35 | |
| Cytoband | 8p11.22 | 4.04e-04 | 14 | 98 | 2 | 8p11.22 | |
| Cytoband | 2q35 | 6.63e-04 | 79 | 98 | 3 | 2q35 | |
| Cytoband | 16q22.2 | 1.01e-03 | 22 | 98 | 2 | 16q22.2 | |
| Cytoband | 10q24.32 | 1.21e-03 | 24 | 98 | 2 | 10q24.32 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.33e-05 | 394 | 51 | 8 | 471 | |
| GeneFamily | Fibronectin type III domain containing | 1.07e-03 | 160 | 51 | 4 | 555 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 1.16e-03 | 18 | 51 | 2 | 620 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.58e-03 | 21 | 51 | 2 | 813 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 3.48e-06 | 30 | 91 | 4 | M47990 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | IL10RA CES1 SPEG GATA6 SIGLEC5 BATF2 HEPH CSF1R PTPRE SMPDL3A CRLF3 PRMT2 C3AR1 ADGRE5 LTBP2 GNS | 5.33e-06 | 1242 | 91 | 16 | M1920 |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | IL10RA CES1 SPEG GATA6 SIGLEC5 BATF2 HEPH CSF1R PTPRE SMPDL3A CRLF3 PRMT2 C3AR1 ADGRE5 LTBP2 GNS | 1.10e-05 | 1316 | 91 | 16 | MM1052 |
| Coexpression | HAHTOLA_SEZARY_SYNDROM_UP | 2.50e-05 | 99 | 91 | 5 | M14577 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | CES1 SIGLEC5 BATF2 CSF1R PTPRE C3AR1 ADGRE5 EIF4E3 MFSD13A TNS1 GNS LILRA5 GAA | 4.62e-05 | 1012 | 91 | 13 | M40868 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#1 | ADAMTSL1 ITGAV STK11IP FNDC1 CSF1R LTBP2 CLCF1 TNS1 GAA TLCD5 | 1.78e-05 | 463 | 86 | 10 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.10e-05 | 420 | 86 | 9 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-07 | 195 | 91 | 7 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.22e-07 | 159 | 91 | 6 | bea6e96ba40ebfc1e38687bfa1c61fe227c5a84d | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.27e-06 | 168 | 91 | 6 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 168 | 91 | 6 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-06 | 174 | 91 | 6 | 4120656e6d6cf5435a248326b5fdbdc7b22137af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.72e-06 | 177 | 91 | 6 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-06 | 178 | 91 | 6 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-06 | 187 | 91 | 6 | 00930e407beaa337f72533a69f32d150faad8b9a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.44e-06 | 188 | 91 | 6 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.44e-06 | 188 | 91 | 6 | e32d95f8e86111245d7f4b5fd72d2471fe0f1304 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-06 | 189 | 91 | 6 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.59e-06 | 190 | 91 | 6 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.67e-06 | 191 | 91 | 6 | 7d00796459f4ff0ab7f06a8379b2d34e76b078b2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.75e-06 | 192 | 91 | 6 | 5ea1a8119012eb8bc3100b739a0430377a8ac534 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.39e-06 | 199 | 91 | 6 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 3.39e-06 | 199 | 91 | 6 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-06 | 199 | 91 | 6 | 0a9783808528bc4c6d797d849a9177330c8fb867 | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.48e-06 | 200 | 91 | 6 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.48e-06 | 200 | 91 | 6 | e57452b73abb21cb3f645d45523ab93f6bef0243 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.48e-06 | 200 | 91 | 6 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.47e-05 | 151 | 91 | 5 | 75c068b3e3aae5f9ba64d5fa5d1e2105a60e4293 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 160 | 91 | 5 | d18c4cc99a31481dd0ee8af9299695d5f6857b42 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 160 | 91 | 5 | a707a4ad9fbedcca227f76b49f1393e88101c2fb | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 160 | 91 | 5 | 73b604cbdcd9e8f0f317964abc632abee314a557 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 160 | 91 | 5 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 160 | 91 | 5 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-05 | 161 | 91 | 5 | 65888250b8c1da6a8f9b5376e086a3769a1cbbd8 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 163 | 91 | 5 | 5fc836444bc156c8248abee001b0ecbe43f980c9 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.12e-05 | 163 | 91 | 5 | b89f586b444f90047c8ce407f53847fd1ee7cca3 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.12e-05 | 163 | 91 | 5 | cbe9b4c4b2e42e9f92a57ed66758af93434db5bb | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.12e-05 | 163 | 91 | 5 | f6c8db5963ee1f8e0c2996f1aeecd58c00e9b099 | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 164 | 91 | 5 | d4cdcd61e8c28b3fb912cef8837cc1a49678a729 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 164 | 91 | 5 | e19fc6ba049336ab989a3a968bdbefd567971d73 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 164 | 91 | 5 | d6526551d0b183c3ef027ba3dbfddeac03fd93bb | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.19e-05 | 164 | 91 | 5 | ea2897942ad72fba900c7ab354d6a9e203bf0e4a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 164 | 91 | 5 | eba25e4d65ca66b5192a7a4d11423f3fa0956828 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 165 | 91 | 5 | 2e9e703c3f89784a47ed40f799d2aa86eba6cc9a | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 165 | 91 | 5 | 9852a4cb680af39c92c7d2d5e5fa8dc04e6602aa | |
| ToppCell | facs-Pancreas-Endocrine-3m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 165 | 91 | 5 | 4d51eb992670bce164eea29b540877b4d567953c | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 165 | 91 | 5 | c629ed33ff14834c32cc1a91116fb079f7aaa94d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 165 | 91 | 5 | 8715ea74d02e9b7cd05fa1b4896b353078544678 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 166 | 91 | 5 | a2ce44702a0cd5fa5872cac3302d3c451205feef | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 166 | 91 | 5 | 961f93f7fb127f449cb1021f6ba73775dc666c53 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 166 | 91 | 5 | 0f641302a6b71c4badaaf20f51162bfc2386b167 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 166 | 91 | 5 | fc71e871084299fb6f006c76f91e72026a290149 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 166 | 91 | 5 | f55fc58572ae6080ac2758462a6b1f3f8b5a93f3 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 166 | 91 | 5 | b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 167 | 91 | 5 | 991a93e1075d562b7391f0689b2f62c1351d48d1 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 167 | 91 | 5 | f22d1471c785b30d096ec5cdc68974e850ed7de0 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 167 | 91 | 5 | 934905aeaafbc215ec8f6a7903498b0e258b9220 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 168 | 91 | 5 | 6514a27a54ea0f07172b3a73270250143a7b14f0 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-05 | 168 | 91 | 5 | eba865465feb0f42055bb8f98946050eeb03d177 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 168 | 91 | 5 | 0b6bb335e93476b13955543eeb487243b0067369 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 168 | 91 | 5 | 8990310df08e7f995bcbf6ee4f288bae42a457d4 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-05 | 168 | 91 | 5 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 168 | 91 | 5 | 94282484033be80b6c0978090c06c0d8fcf17e9e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-05 | 168 | 91 | 5 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 168 | 91 | 5 | 7d4ddcc03a16ecdc23f961b94e864e6cf110820d | |
| ToppCell | PND07-28-samps-Myeloid|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.45e-05 | 168 | 91 | 5 | 87512f9e5e95333e7ffc6efa1e93bab2ba9154c6 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 169 | 91 | 5 | 0e3d0b71fc21fd1de7034d13895608de5494fad8 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 169 | 91 | 5 | 411556e93adcbb7e4d79b02f3dc72963ec8a0759 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 169 | 91 | 5 | 39b1acfd099abb9de18c29c05c7a67709ea76775 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 169 | 91 | 5 | c68a305069a149d66dfdeef2a8010f460dc1da3b | |
| ToppCell | facs-Pancreas-Endocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 169 | 91 | 5 | 80089dfb1f0f4d6bdf6ca161e902b38011992dfd | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 170 | 91 | 5 | 8d3c51364a332020810836e2055c60893c10d7f3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 171 | 91 | 5 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-monocytoid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.75e-05 | 172 | 91 | 5 | 9befd44bce43eb5dc1fe3d2e44608f442cf74a47 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 172 | 91 | 5 | 51bea97564a33f0060c546c9be4bf8bf8f1660f6 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.75e-05 | 172 | 91 | 5 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.75e-05 | 172 | 91 | 5 | 5f58ff6cac32546d07b2a49ed250b6c7aa417188 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 172 | 91 | 5 | be4dd4ba8d7a651677c797c25fd75f14e627415a | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 173 | 91 | 5 | a664dbd7fb55b1c4309fa5f9425bc83924dac545 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-05 | 173 | 91 | 5 | 34416c583eaa21ce447d9b67bb420e35d05acc25 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 173 | 91 | 5 | 054f64462b648ba6b4b28b48c716dc01b2ddd790 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 173 | 91 | 5 | 9a8fec9a08bb61456a4ea43ae1316bd3e197a773 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 175 | 91 | 5 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 175 | 91 | 5 | e991ffa4d1d278a011592b9915cd35fe76db20cc | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-05 | 177 | 91 | 5 | cdad5a2f672a7f07c05669bfcaf1ec74defd3de7 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-05 | 177 | 91 | 5 | 991ae76bb615392d84aeb89886148fa42c1c649c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.24e-05 | 178 | 91 | 5 | 8184a2b9872f7ca12a9823535de485e841aeffb1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-05 | 179 | 91 | 5 | 409364d916c5e7e2291284cc74351d8f8a8447ac | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-05 | 180 | 91 | 5 | 97241f62ee133dcb0d4855ffda5dd1349de9f7b2 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-05 | 180 | 91 | 5 | 41896546cd1cc458e08c0d4e19aa4860e5d4fcd6 | |
| ToppCell | Control-Myeloid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 181 | 91 | 5 | 25170e5285996cc80337d5f86a0255569861ae77 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.60e-05 | 182 | 91 | 5 | d5d6bc16458bc665e7ad6669040d79f73f640044 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.60e-05 | 182 | 91 | 5 | 0b59ead4bb4486c7ec2ee90b94ee3a09905612c5 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.60e-05 | 182 | 91 | 5 | 7b86703559438e2d5ef3dad963ee0d772513f313 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-05 | 183 | 91 | 5 | 92d5a61b57851090eba558f19e2a7010043eff81 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-05 | 184 | 91 | 5 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.89e-05 | 185 | 91 | 5 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-05 | 186 | 91 | 5 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-05 | 186 | 91 | 5 | ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-05 | 188 | 91 | 5 | 4e27ada1bda88811b73376c8a6136cbfc83bfdb9 | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.31e-05 | 189 | 91 | 5 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-05 | 189 | 91 | 5 | 3b5e1a8d5c1e1fa2124f64f212e9c6b8f1b7d7da | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.41e-05 | 190 | 91 | 5 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.41e-05 | 190 | 91 | 5 | 47513757e0059e8370e49672a577f25ca842e98c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.41e-05 | 190 | 91 | 5 | 0a944da2aaaef9289b2a4ffe360b0338724fd59b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 190 | 91 | 5 | 7c402aa47f1bd7decacc366c1ed1a37e39b95c73 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-05 | 190 | 91 | 5 | 4cce4ddb79b7751d0103e10f71156977e0c34439 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, polybrominated diphenyl ether measurement | 7.77e-05 | 5 | 83 | 2 | EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | benign neoplasm (implicated_via_orthology) | 2.16e-04 | 8 | 83 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | kidney cancer (implicated_via_orthology) | 4.23e-04 | 11 | 83 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | carcinoma (implicated_via_orthology) | 7.90e-04 | 64 | 83 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 8.63e-04 | 261 | 83 | 5 | C0004352 | |
| Disease | cutaneous Leishmaniasis | 9.14e-04 | 16 | 83 | 2 | EFO_0005046 | |
| Disease | acetone measurement | 1.30e-03 | 19 | 83 | 2 | EFO_0010989 | |
| Disease | Cerebral Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0334583 | |
| Disease | Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 2.25e-03 | 25 | 83 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 2.25e-03 | 25 | 83 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 2.43e-03 | 26 | 83 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 2.43e-03 | 26 | 83 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 2.43e-03 | 26 | 83 | 2 | C0334582 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 2.43e-03 | 26 | 83 | 2 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | Anaplastic astrocytoma | 2.62e-03 | 27 | 83 | 2 | C0334579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSQWESPSFNPFGSH | 386 | O75410 | |
| FHPTQPWVFSSGADG | 726 | Q14137 | |
| HWGFPALTEPSASPA | 46 | O43414 | |
| AWGHPSSPPVVDTVH | 16 | P23141 | |
| VVGFHTAWEPSRPFP | 236 | O94766 | |
| PQVLSTGPFHPTTHW | 356 | P55345 | |
| AWIPFQVPGTAHPSP | 121 | Q5SQH8 | |
| QASPAVPVPHFTTWG | 51 | Q5T6M2 | |
| VPVPHFTTWGSLIPI | 56 | Q5T6M2 | |
| VWVQDTPFSTPSHPF | 311 | Q9N2J8 | |
| PTLPVWAVAPVSAVH | 36 | Q8N8Q8 | |
| GWGFPLVPTTIHAIT | 266 | P30988 | |
| PWVSPHNPAFATESP | 691 | Q12774 | |
| FSTWTPPPGVHSQTL | 261 | P48960 | |
| PSSGSWVQPHTPQSL | 4346 | Q96M86 | |
| HPWTVPTVFQPQTFQ | 221 | Q16581 | |
| PSAQPWTHPGQSQLF | 46 | Q16853 | |
| GGSPWLHVIIAFPTS | 56 | Q92617 | |
| FQPEEASPWTQPGVH | 156 | Q96DU7 | |
| PAFPQSPNWHFPVSD | 86 | P50221 | |
| GGSPWLHVIIAFPTS | 56 | F8W0I5 | |
| GSPTPVLHVGWATFL | 431 | O00255 | |
| PPLEGHIPTWGFNSV | 101 | Q8N8L6 | |
| FTHWIPVPTSSTPGT | 12661 | Q8WXI7 | |
| LHFTSWPDFGVPFTP | 296 | P23469 | |
| QALFPVGPVTPSHRW | 196 | A6NI73 | |
| SSGHEIPTWQPNIPV | 446 | O95835 | |
| TAVGPSHPAWVPAPA | 456 | Q9NRM7 | |
| WATNPGLFSQPVPAV | 106 | Q15742 | |
| SWVAGSFSPVSPPVV | 1106 | Q9P2D0 | |
| RNPPPAIGQFWHVTD | 31 | Q92484 | |
| AEPSAPHQAWQPTAS | 786 | Q5VZ46 | |
| PNITWFHGGQPIVTA | 1426 | Q8N6G6 | |
| HSPTGWSAPSNPVVI | 101 | P43629 | |
| PWSVPQIGHSTLVPH | 261 | Q8IUI8 | |
| HSPTGWSAPSNPVVI | 101 | Q8N743 | |
| HIEPSFSPWNSPVFV | 61 | P63132 | |
| GGSPWLHVIIAFPTS | 56 | A8MRT5 | |
| AHGTELPSPPSVWFE | 21 | Q13651 | |
| GGSPWLHVIIAFPTS | 56 | C9JG80 | |
| HIEPSFSPWNSPVFV | 61 | P63135 | |
| HIEPSFSPWNSPVFV | 61 | Q9BXR3 | |
| HLFSWEPGGPVTVSV | 351 | O77932 | |
| QPEPGGVPLHSSWTF | 41 | Q8N5X7 | |
| FTAWPEHGVPENSAP | 2196 | Q9UMZ3 | |
| APVFGASWAPLSPHA | 56 | P17482 | |
| HIEPSFSPWNSPVFV | 61 | Q9QC07 | |
| FSTLSSHQPVAWPNP | 286 | Q9HAP2 | |
| PSWSGIRNATHFPPV | 91 | Q9NZ94 | |
| TPAWPAGPFETPVLH | 346 | Q92908 | |
| WAFIPISAGAHTHPP | 496 | P07333 | |
| HWAEGSPQPFSVEPS | 3881 | Q4G0P3 | |
| FWLVHSVPNFPPPAS | 126 | O00115 | |
| VQGFWLIHSIPQFPP | 136 | Q8WZ79 | |
| AGDPTAHQPFWAPPT | 56 | Q9C0J1 | |
| AATVSPVAGTHPWPQ | 1266 | Q4ZHG4 | |
| PVAGTHPWPQYTTRA | 1271 | Q4ZHG4 | |
| SPTHLWTGEVSAAPP | 156 | Q6P1L5 | |
| AATWQGLVVDPSPHP | 246 | Q8N1L9 | |
| GVSSPDHVFLPIPNW | 776 | P06756 | |
| THTIFEPTPFWVPNN | 421 | Q6UWU2 | |
| PSHQPAQSFGLWVPQ | 126 | Q8IX06 | |
| PAIHSEGQWVTLPAP | 796 | P10253 | |
| GTQQAVPLEHPSSPW | 326 | Q14767 | |
| TPAPHSPWTAAPQYQ | 231 | P15586 | |
| WTPQPLQAAAPSHEF | 41 | Q52M75 | |
| FLVPTATTWPGVAHV | 201 | Q86YV9 | |
| LPPSNSYWAGHTPEQ | 541 | A6NKX4 | |
| QQSLITPVGSAHPWP | 436 | Q14CX5 | |
| TGQHPEVPPAFWNNA | 196 | Q9BVI4 | |
| GGSPWLHVIIAFPTS | 56 | A6NJU9 | |
| PQHPASLSGTWTVYP | 71 | P19526 | |
| PIAHQWPQGPSAVDA | 296 | P02790 | |
| LNPSPAGWFVQQHPE | 401 | Q8N1F8 | |
| AWVSPSETHPVSAQP | 1151 | Q6WKZ4 | |
| ATGQLTVPPWHPQSS | 946 | Q8IWB6 | |
| AWPSFPTQDHLPATP | 16 | Q13275 | |
| VPLAPPVWTAPTFTH | 646 | Q15572 | |
| TYRWTVPPHAGPTAQ | 516 | Q9BQS7 | |
| APSNPPAHLSWFQGS | 271 | O15389 | |
| PGIGVWNPAFDVTPH | 316 | Q9BV20 | |
| ITCVPGHPSQWTSQP | 811 | Q6UXD5 | |
| TAWGSFIHTPGPELQ | 91 | Q9NZ20 | |
| AWPLSTLPVFHPVTG | 381 | O43556 | |
| QTGVSTWHDPRIPSP | 256 | Q9HCE7 | |
| GTVFVSWVPPPAENH | 361 | Q8WZ75 | |
| EPTWTPGPAHSDFLQ | 166 | Q9UBD9 | |
| HIEPSFSPWNSPVFV | 61 | P63136 | |
| VPRPHSGLWVQSDFP | 106 | Q1ZZU3 | |
| WPFTHPGSPNTPLQV | 61 | Q6ZRR5 | |
| KISGTPPPVVTWTHF | 1086 | Q15772 | |
| HSPGPVVAIASTWNS | 596 | A6NE52 | |
| PHPAWPQPVTTSHYA | 596 | Q9HBL0 | |
| HIEPSFSPWNSPVFV | 61 | P10266 | |
| HIEPSFSPWNSPVFV | 61 | P63133 | |
| PHVPPSFVGKTWSQI | 1821 | Q9HCK1 | |
| HIEPSFSPWNSPVFV | 61 | Q9UQG0 | |
| IARSQIFVFGPHWPP | 386 | Q7Z4N2 | |
| FSPNSLVALPGHIPW | 406 | Q9UDV6 | |
| VGHVPGEFPVSVWVT | 96 | Q8N3G9 | |
| HIEPSFSPWNSPVFV | 61 | Q9WJR5 | |
| ANGVWHPFVTVAPLG | 1161 | A3KMH1 | |
| PVWGPHVPESAFATC | 4921 | Q5T4S7 |